β-Secretase (BACE1) Inhibitors with High in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer’s DiseaseHans Hilpert, Robert Narquizian, Roland Humm et al.|Journal of Medicinal Chemistry|2013Cited by 138